Speaker Profile
CEO, InSilicoTrials
Biography
Luca is a seasoned entrepreneur and expert in technology and healthcare, with a longstanding focus on advancing modeling and simulation within the life sciences sector. Prior to his current endeavors, he was the CEO of Emaze, a cybersecurity firm that specialized in automated security analysis for complex networks. He is actively involved in several advisory roles, including the Cloud Security Consultative Group at EMA, Co-chair of Avicenna Alliance's Good Simulation Practice (GSP) Task Force and member of the committee for the adoption of In Silico Medicine of the Italian Ministry of Health. He is also co-editor of the open-access book "Toward Good Simulation Practice: Best Practices for the Use of Computational Modeling Simulation in the Regulatory Process of Biomedical Products, published open access by Nature Springer in February 2024.
Talk
Transforming Clinical Trial Simulation with Causal GenAI
We explore how InSilicoTrials leverages Causal GenAI and advanced Digital Twin technologies to transform clinical trial simulation. Discover how AI-driven modeling accelerates study design, reduces risk, and enhances decision-making, enabling faster, smarter, and more efficient drug development.
AI for Clinical Decision Support Systems Showcase:
InSilicoTrials
We provide a cloud-based platform that uses in silico modeling, predictive AI, and synthetic patient simulations to generate robust, regulatory-grade digital evidence; accelerating the go-to-market timeline and extending market exclusivity up to 4 years.
Session Abstract – PMWC 2026 Silicon Valley
"The PMWC 2026 AI for Clinical Decision Support Showcase will provide a 15-30 minute time slot for selected organizations, including commercial companies, clinical testing labs, and medical research institutions, to present their latest advancements, insights, applications, and technologies to an audience of clinicians, leading investigators, academic institutions, pharma and biotech, investors, and potential clients. We will learn about new technologies and findings that promise expedited, cost-effective, and accurate clinical diagnosis for early disease detection, treatment decisions, and disease prevention.
- Clinical Dx/Oncology (including Liquid Biopsy)
- Clinical Dx/Cardio Vascular
- Clinical Dx/Neurodegenerative
